| Date | Title | Description |
| 23.07.2024 | Sedana Medical AB’s Interim report January-June 2024 | Sedana Medical AB’s Interim report January-June 2024
Tue, Jul 23, 2024 07:00 CET Report this content
Enrolment of both US clinical trials completed, on track for first results in 2H.
Second quarter 2024
Net sales for the quarter totaled MSE... |
| 22.07.2024 | Sedana Medical to acquire its main supplier to take control of supply chain and reduce cost of goods | Sedana Medical to acquire its main supplier to take control of supply chain and reduce cost of goods
Mon, Jul 22, 2024 20:00 CET Report this content
Sedana Medical AB (publ) announces it has today entered into an agreement to acquire Innova... |
| 16.07.2024 | Invitation to presentation of Sedana Medical’s interim report for the second quarter 2024 | Invitation to presentation of Sedana Medical’s interim report for the second quarter 2024
Tue, Jul 16, 2024 08:00 CET Report this content
Sedana Medical AB (publ) plans to present its interim report for the second quarter of 2024 on Tuesday... |
| 29.05.2024 | Sedana Medical completes patient recruitment for its clinical program in the US | Sedana Medical completes patient recruitment for its clinical program in the US
Wed, May 29, 2024 08:00 CET Report this content
Sedana Medical AB (publ) announces that all 235 randomized patients have been recruited for its INSPiRE-ICU 2 ph... |
| 22.05.2024 | Report from Sedana Medical’s annual general meeting on 22 May 2024 | Report from Sedana Medical’s annual general meeting on 22 May 2024
Wed, May 22, 2024 16:30 CET Report this content
Sedana Medical AB (publ)’s annual general meeting was held on Wednesday, 22 May 2024 and the main resolutions passed were the... |
| 25.04.2024 | Sedana Medical completes patient recruitment for INSPiRE-ICU 1 clinical trial in the US | Sedana Medical completes patient recruitment for INSPiRE-ICU 1 clinical trial in the US
Thu, Apr 25, 2024 06:45 CET Report this content
Sedana Medical AB (publ) announces that all 235 randomized patients have been recruited for its INSPiRE-... |
| 25.04.2024 | Sedana Medical AB's Interim report January-March 2024 | Sedana Medical AB's Interim report January-March 2024
Thu, Apr 25, 2024 07:00 CET Report this content
Off to a strong start with record sales in Q1
First quarter 2024
Net sales for the quarter totalled MSEK 48.8 (37.8), equivalent to an inc... |
| 22.04.2024 | Notice of Annual General Meeting in Sedana Medical | Notice of Annual General Meeting in Sedana Medical
Mon, Apr 22, 2024 08:30 CET Report this content
The board of directors of Sedana Medical AB (publ) has resolved to convene an annual general meeting of shareholders to be held Wednesday, 22... |
| 15.04.2024 | Sedana Medical publishes its Annual Report for 2023 | Sedana Medical publishes its Annual Report for 2023
Mon, Apr 15, 2024 21:02 CET Report this content
Sedana Medical AB (publ) publishes its Annual Report for 2023. The Annual Report describes important events and financial information for 20... |
| 05.04.2024 | Invitation to presentation of Sedana Medical’s interim report for the first quarter 2024 | Invitation to presentation of Sedana Medical’s interim report for the first quarter 2024
Fri, Apr 05, 2024 08:00 CET Report this content
Sedana Medical AB (publ) plans to present its interim report for the first quarter of 2024 on Thursday ... |
| 15.02.2024 | Sedana Medical AB’s Year-end report 2023 | Sedana Medical AB’s Year-end report 2023
Thu, Feb 15, 2024 07:00 CET Report this content
Full year sales at upper end of financial guidance and an exciting year ahead
Fourth quarter 2023
Net sales for the quarter totalled MSEK 44.5 (35.8), ... |
| 16.11.2023 | Key results of Sedana Medical’s paediatric study IsoCOMFORT published | Key results of Sedana Medical’s paediatric study IsoCOMFORT published
Thu, Nov 16, 2023 08:00 CET Report this content
Sedana Medical AB (publ) today announces that the main results from the paediatric IsoCOMFORT study have been published in... |
| 26.10.2023 | Sedana Medical AB’s Interim report January-September 2023 | Sedana Medical AB’s Interim report January-September 2023
Thu, Oct 26, 2023 07:00 CET Report this content
All-time-high Q3 sales and further steps towards ex-US profitability
Third quarter 2023 Net sales for the quarter totalled MSEK 34.3 (... |
| 24.10.2023 | Sedana Medical’s Nomination Committee established | Sedana Medical’s Nomination Committee established
Tue, Oct 24, 2023 08:00 CET Report this content
According to the principles for the appointment of the Nomination Committee in Sedana Medical AB (publ), the Nomination Committee for the Annu... |
| 23.10.2023 | The SESAR investigator-initiated trial completes patient enrollment | The SESAR investigator-initiated trial completes patient enrollment
Mon, Oct 23, 2023 08:00 CET Report this content
Sedana Medical AB (publ) today announces that the enrollment of the planned 700 patients in the SESAR trial has been complet... |
| 21.07.2023 | Sedana Medical AB’s Interim report January-June 2023 | Sedana Medical AB’s Interim report January-June 2023
Fri, Jul 21, 2023 07:00 CET Report this content
Strong sales momentum and a clear target to achieve EBITDA break-even in our Ex-US business during 2024
Second quarter 2023 Net sales for t... |
| 16.05.2023 | Report from Sedana Medical AB’s annual general meeting on May 16, 2023 | Report from Sedana Medical AB’s annual general meeting on May 16, 2023
Tue, May 16, 2023 15:00 CET Report this content
Sedana Medical AB’s annual general meeting was held on Tuesday, May 16, 2023. The main resolutions passed were the follow... |
| 27.04.2023 | Sedana Medical AB’s Interim report January-March 2023 | Sedana Medical AB’s Interim report January-March 2023
Thu, Apr 27, 2023 07:00 CET Report this content
Back to growth
First quarter 2023 Net sales for the quarter totalled MSEK 37.8 (33.7), equivalent to an increase of 12% compared to 2022. ... |
| 05.04.2023 | Notice of Annual General Meeting in Sedana Medical | Notice of Annual General Meeting in Sedana Medical
Wed, Apr 05, 2023 08:30 CET Report this content
The board of directors of Sedana Medical AB (publ) has resolved to convene an annual general meeting of shareholders to be held Tuesday, 16 M... |
| 16.02.2023 | Sedana Medical AB’s Year-end report 2022 | Sedana Medical AB’s Year-end report 2022
Thu, Feb 16, 2023 07:00 CET Report this content
Fast track designation in the US and our strongest quarter in 2022
Fourth quarter 2022 Net sales for the quarter totalled MSEK 35.8 (46.4), equivalent ... |
| 21.07.2022 | Sedana Medical AB Interim report January-June 2022 | Sedana Medical AB Interim report January-June 2022
Thu, Jul 21, 2022 07:00 CET Report this content
Committed to change the standard of care, with commercial progress and a strong balance sheet.
Second quarter 2022 Net sales for the quarter ... |
| 11.05.2022 | Bulletin from the annual general meeting in Sedana Medical AB (publ) | Bulletin from the annual general meeting in Sedana Medical AB (publ)
Wed, May 11, 2022 12:00 CET Report this content
Today, the annual general meeting of Sedana Medical AB (publ) (SEDANA: FN Stockholm) was held. In order to counteract the s... |
| 28.04.2022 | Sedana Medical AB Interim report January-March 2022 | Sedana Medical AB Interim report January-March 2022
Thu, Apr 28, 2022 07:00 CET Report this content
First patient enrolled in US clinical program
First quarter 2022 Net sales totalled MSEK 34 (45), equivalent to a decrease of 25% compared t... |
| 07.04.2022 | Notice of Annual General Meeting in Sedana Medical AB (publ) | Notice of Annual General Meeting in Sedana Medical AB (publ)
Thu, Apr 07, 2022 10:45 CET Report this content
The shareholders in Sedana Medical AB (publ), reg. no. 556670-2519, are hereby given notice to attend the annual general meeting to... |
| 07.04.2022 | Correction Sedana Medical publishes Annual Report 2021 | Correction Sedana Medical publishes Annual Report 2021
Thu, Apr 07, 2022 16:10 CET Report this content
The correction refers to incorrect reference to the Market Abuse Regulation, which was removed in this press release.
In addition to sign... |
| 07.04.2022 | Sedana Medical publishes Annual Report 2021 | Sedana Medical publishes Annual Report 2021
Thu, Apr 07, 2022 15:00 CET Report this content
Sedana Medical AB (publ) (SEDANA: FN Stockholm) published its Annual Report 2021.
In addition to significant events and financial information of 202... |
| 17.02.2022 | Sedana Medical AB fourth quarter and year-end report 2021 | Sedana Medical AB fourth quarter and year-end report 2021
Thu, Feb 17, 2022 07:00 CET Report this content
Sales at an all-time-high provide a strong platform for launch
Fourth quarter 2021 Net sales totalled MSEK 46 (46), equivalent to an i... |
| 23.12.2021 | Sedana Medical receives IND approval for US trial | STOCKHOLM, Dec. 23, 2021 /PRNewswire/ -- Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announces that the company has received Investigational New Drug (IND) clearance from the US Food and Drug Administration (FDA) to initiate phase... |
| 02.12.2021 | Sedana Medical announces intention to carry out a directed share issue of approximately 600 MSEK | NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, HONG KONG, CANADA, NEW ZEALAND, JAPAN, SINGAPORE OR SOUTH AFRICA OR ANY OTHER JURISDICTION IN WH... |
| 04.11.2021 | Sedana Medical AB (publ), Third Quarter Report 2021 | Sedana Medical AB (publ), Third Quarter Report 2021 Thu, Nov 04, 2021 07:00 CET
Sedaconda (isoflurane) approved in 11 European markets
Third quarter 2021 Net sales totalled SEK 28 M (21), equivalent to an increase of 32% compared to the thi... |
| 26.10.2021 | Sedana Medical’s Nomination committee appointed | Sedana Medical’s Nomination committee appointed Tue, Oct 26, 2021 08:30 CET
Sedana Medical AB (publ) today publish that in accordance with the resolution of the Annual General Meeting on May 10, 2021, the Chairman of the Board has contacted... |
| 19.08.2021 | Sedana Medical AB (publ), Second Quarter Report 2021 | Sedana Medical AB (publ), Second Quarter Report 2021 Thu, Aug 19, 2021 07:00 CET
European approval of Sedaconda
Second quarter 2021
Net sales totalled MSEK 40 (41), equivalent to a decrease of 2 percent compared to the second quarter of 202... |
| 18.05.2021 | Record date for division of shares (split) in Sedana Medical determined to May 27, 2021 | Record date for division of shares (split) in Sedana Medical determined to May 27, 2021 Tue, May 18, 2021 16:00 CET
At the annual general meeting of Sedana Medical AB (publ) (SEDANA: FN Stockholm) held May 10, 2021, it was resolved, in acco... |
